Singapore markets closed

Straits Times Index
3,336.59
+13.21(+0.40%)
Nikkei
38,487.90
+433.77(+1.14%)
Hang Seng
18,079.61
-150.58(-0.83%)
FTSE 100
8,275.38
+44.33(+0.54%)
Bitcoin USD
67,690.98
+100.31(+0.15%)
CMC Crypto 200
1,424.58
-3.99(-0.28%)

VKTX Jun 2024 83.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.2000

-0.2500

(-55.56%)

At close: 01:30PM EDT

Zacks
Here's Why Viking Therapeutics, Inc. (VKTX) Gained But Lagged the Market Today
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.26, representing a +0.78% change from its previous close.
PR Newswire
Viking Therapeutics to Participate at Upcoming Investor Conferences
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at two upcoming investor conferences.
Zacks
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?